C. Su
发表
J. O’Shea,
A. Milici,
B. Reitz,
2003,
Science.
L. Buckbinder,
K. Stone,
Adam G Schwaid,
2015,
ACS chemical biology.
A. Kalgutkar,
T. Maurer,
L. Buckbinder,
2015,
The Journal of Pharmacology and Experimental Therapeutics.
Huiyong Shen,
Yanfeng Wu,
Shan Wang,
2020,
The Journal of international medical research.
Huiyong Shen,
Yanfeng Wu,
Peng Wang,
2019,
Stem cells international.
L. Pustilnik,
J. Christensen,
B. D. Cohen,
2010,
Molecular Cancer Therapeutics.
Guanglin Zhang,
Gangsheng Wang,
Tao Yang,
2020,
Oncology reports.
Achieving selectivity between highly homologous tyrosine kinases: a novel selective erbB2 inhibitor.
Matthew D. Wessel,
A. Mathiowetz,
L. Pustilnik,
2003,
Biochemical and biophysical research communications.
C. Su,
Yaling Shi,
Changchun Lai,
2020,
Cancer management and research.
A. Kalgutkar,
L. Buckbinder,
E. Keliher,
2019,
PloS one.
John W. Chen,
G. Wojtkiewicz,
L. Buckbinder,
2023,
International journal of molecular sciences.
C. Su,
Yaling Shi,
Changchun Lai,
2020
.
Gangsheng Wang,
C. Su,
Xuqun Huang,
2020,
Biocell (Mendoza).
L. Pustilnik,
S. Bhattacharya,
J. Chen,
2007,
Bioorganic & medicinal chemistry letters.